Share this postSnowball ResearchVenus Concept (VERO): This nano-cap company ($100M+ revenue) appoints a new CEO who is a former top executive of Valeant Pharmaceuticals; Mixed track recordCopy linkFacebookEmailNotesMoreVenus Concept (VERO): This nano-cap company ($100M+ revenue) appoints a new CEO who is a former top executive of Valeant Pharmaceuticals; Mixed track recordApr 26, 2024∙ PaidShare this postSnowball ResearchVenus Concept (VERO): This nano-cap company ($100M+ revenue) appoints a new CEO who is a former top executive of Valeant Pharmaceuticals; Mixed track recordCopy linkFacebookEmailNotesMoreShareVenus Concept (VERO) - Oct 2022662KB ∙ PDF fileDownloadDownload This post is for paid subscribersSubscribeAlready a paid subscriber? Sign inPreviousNext